hydroxyurea (Hydrea, Droxia)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

Cancer 101: Cancer Explained

What is hydroxyurea-oral, and how does it work (mechanism of action)?

Hydroxyurea (Hydrea) is an oral medication used to treat several types of cancers including chronic myelogenous leukemia (CML), acute myelogenous leukemia (AML), head and neck cancer, malignant melanoma, ovarian cancer, and polycythemia vera (a disorder of the bone marrow). The exact mechanism by which hydroxyurea works to treat cancer is not understood. However, it is thought that hydroxyurea causes an immediate inhibition of DNA synthesis by inhibiting an enzyme called ribonucleotide reductase. Interrupting DNA synthesis reduces the growth of cancer cells.

In-addition to treating cancer, Droxia another oral form of hydroxyurea is used in the management of sickle cell disease. The exact mechanism by which hydroxyurea works to treat sickle cell disease is not understood. The FDA approved hydroxyurea in December 1967.

What brand names are available for hydroxyurea-oral?

Hydrea, Droxia

Is hydroxyurea-oral available as a generic drug?

GENERIC AVAILABLE: Yes

Do I need a prescription for hydroxyurea-oral?

Yes

What are the side effects of hydroxyurea-oral?

Known side effects include:

Quick GuidePancreatic Cancer Symptoms, Causes, and Treatment

Pancreatic Cancer Symptoms, Causes, and Treatment

What is the dosage for hydroxyurea-oral?

For treating cancer: Dose should be titrated based on individual patient response. Capsules should be swallowed whole. Hydroxyurea capsules should be handled with extreme care and disposed of properly because it causes cell damage.

For the treatment of solid tumors

  • Intermittent therapy: 80 mg/kg administered orally as single dose every third day
  • Continuous therapy: 20 to 30 mg/kg administered orally as a single daily dose
  • Concomitant therapy with irradiation: Cancer of the head and neck, administer 80 mg/kg orally as a single dose every third day

For the treatment of chronic myelocytic leukemia

20 to 30 mg/kg administered orally as a single daily dose is recommended.

As hydroxyurea is mainly eliminated from the body via the kidneys, dose reductions may be necessary in patients with reduced kidney function.

For the treatment of sickle cell disease

Adults: administer 15 mg/kg by mouth once daily. Dose adjustments are made based on patient's blood counts. Patient's blood counts are monitored every two weeks. If the blood counts are in an "acceptable" range, the dose may be increased by 5 mg/kg/day every 12 weeks until a maximum tolerated dose (highest dose that does not produce toxic blood counts) or 35 mg/kg/day is reached.

Which drugs or supplements interact with hydroxyurea-oral?

:

Generally, use of live vaccines is contraindicated during treatment with cancer drugs because cancer drugs weaken the immune system. People with weakened immune systems have a decreased response to vaccines.

Hydroxyurea may cause a drop in platelet counts, an important type of blood cells required for forming blood clots. Use of hydroxyurea with anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), antiplatelets, and thrombolytic agents increases the risk of bleeding.

Antineoplastic agents exert their benefits by killing rapidly growing cancer cells. Use of medications that stimulate cell growth is usually not recommended in patients who have been exposed to cytotoxic chemotherapy within 24 hours. Specifically, the manufacturer of pegfilgrastim (Neulasta) recommends that pegfilgrastim should not be administered to patients who have been treated with cytotoxic chemotherapy within the prior 14 days. Also, chemotherapy should not be administered within 24 hours of pegfilgrastim.

Hydroxyurea may increase blood uric acid concentration. Although no specific dose adjustments are necessary with probenecid or sulfinpyrazone (Anturane), hydroxyurea should be used cautiously with uricosuric medications.

Use of hydroxyurea with didanosine (Videx, Videx EC), with or without stavudine (Zerit, Zerit XR), has been associated with an increased incidence of side effects including pancreatitis and peripheral neuropathy (nerve problems). In general, hydroxyurea is not recommended in HIV patients as decreased CD4 counts, decreased viral suppression, and increased risk of side effects has been reported.

Is hydroxyurea-oral safe to take if I'm pregnant or breastfeeding?

Hydroxyurea can cause harm to the unborn baby and therefore, should not be used during pregnancy. Although there are no adequate and well-controlled studies in pregnant women, in animals studies hydroxyurea was found to cause birth defects.

Hydroxyurea is secreted in human milk. Nursing should be stopped due to the potential for serious adverse reactions in the infant.

What else should I know about hydroxyurea-oral?

What preparations of hydroxyurea-oral are available?

  • Hydrea: 500 mg capsules. Hydrea is used an antineoplastic agent.
  • Droxia: 200 mg, 300 mg, 400 mg capsules. Droxia is used to treat sickle cell disease.

How should I keep hydroxyurea-oral stored?

Capsules should be stored at room temperature between 59 F to 86 F (15 C to 30 C).

REFERENCE: FDA Prescribing Information.

Quick GuidePancreatic Cancer Symptoms, Causes, and Treatment

Pancreatic Cancer Symptoms, Causes, and Treatment

Summary

Hydroxyurea (Hydrea, Droxia) is a prescription drug used to treat several types of cancer including types of leukemia, head and neck cancer, malignant melanoma, and ovarian cancer; and polycythemia vera. Side effects, drug interactions, warnings, precautions, dosing, storage, pregnancy, and breastfeeding safety information is included.

Treatment & Diagnosis

Medications & Supplements

Prevention & Wellness

Subscribe to MedicineNet's Cancer Report Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Reviewed on 6/9/2015
References
REFERENCE: FDA Prescribing Information.

Health Solutions From Our Sponsors